Among them, statistical differences were observed in age, race, weight, MAP, respiration rate, WBC, hemoglobin, alanine aminotransferase, creatinine, serum BUN, albumin, BAR, vasopressors, renal replacement therapy, mechanical ventilation, congestive heart failure, myocardial infarction, renal disease, Charlson comorbidity index, SAPS II, LOS in ICU, LOS in hospital, ICU mortality, in-hospital mortality, 28-day and 90-day mortality (P < 0.05) as demonstrated in Table 1. This evidence concerns the gene GPT and congestive heart failure.